BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17629053)

  • 1. Cyclooxygenase-2 expression in gastroenteropancreatic neuroendocrine tumors.
    Ince AT; Ovünç O; Celikel CA; Göksel S; Tosun S; Peker O
    Hepatogastroenterology; 2007 Jun; 54(76):1125-9. PubMed ID: 17629053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methyltransferases 1, 3a, and 3b overexpression and clinical significance in gastroenteropancreatic neuroendocrine tumors.
    Rahman MM; Qian ZR; Wang EL; Yoshimoto K; Nakasono M; Sultana R; Yoshida T; Hayashi T; Haba R; Ishida M; Okabe H; Sano T
    Hum Pathol; 2010 Aug; 41(8):1069-78. PubMed ID: 20381114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of nuclear p27 expression and its prognostic role in relation to cyclin E and p53 mutation in gastroenteropancreatic neuroendocrine tumors.
    Grabowski P; Schrader J; Wagner J; Hörsch D; Arnold R; Arnold CN; Georgieva I; Stein H; Zeitz M; Daniel PT; Sturm I
    Clin Cancer Res; 2008 Nov; 14(22):7378-84. PubMed ID: 19010853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of an activated mammalian target of rapamycin (mTOR) in gastroenteropancreatic neuroendocrine tumors.
    Shida T; Kishimoto T; Furuya M; Nikaido T; Koda K; Takano S; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Tanizawa T; Nakatani Y; Miyazaki M
    Cancer Chemother Pharmacol; 2010 Apr; 65(5):889-93. PubMed ID: 19657638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma.
    Kolev Y; Uetake H; Iida S; Ishikawa T; Kawano T; Sugihara K
    Ann Surg Oncol; 2007 Oct; 14(10):2738-47. PubMed ID: 17687613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear survivin is a powerful novel prognostic marker in gastroenteropancreatic neuroendocrine tumor disease.
    Grabowski P; Griss S; Arnold CN; Hörsch D; Göke R; Arnold R; Heine B; Stein H; Zeitz M; Scherübl H
    Neuroendocrinology; 2005; 81(1):1-9. PubMed ID: 15809513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification.
    Klöppel G; Couvelard A; Perren A; Komminoth P; McNicol AM; Nilsson O; Scarpa A; Scoazec JY; Wiedenmann B; Papotti M; Rindi G; Plöckinger U; ;
    Neuroendocrinology; 2009; 90(2):162-6. PubMed ID: 19060454
    [No Abstract]   [Full Text] [Related]  

  • 8. Angiopoietin-2 promotes disease progression of neuroendocrine tumors.
    Detjen KM; Rieke S; Deters A; Schulz P; Rexin A; Vollmer S; Hauff P; Wiedenmann B; Pavel M; Scholz A
    Clin Cancer Res; 2010 Jan; 16(2):420-9. PubMed ID: 20068079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
    Chetty R; Serra S; Asa SL
    Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic neuroendocrine tumors. Report of nine cases.
    García-Sancho Téllez L; Rodriguez Montes JA; Burgos Lizáldez E; García-Sancho Martin L
    Hepatogastroenterology; 2000; 47(35):1458-61. PubMed ID: 11100376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas.
    Li X; Zheng H; Hara T; Takahashi H; Masuda S; Wang Z; Yang X; Guan Y; Takano Y
    Int J Oncol; 2008 Jul; 33(1):69-79. PubMed ID: 18575752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary and extrapulmonary poorly differentiated large cell neuroendocrine carcinomas: diagnostic and prognostic features.
    Faggiano A; Sabourin JC; Ducreux M; Lumbroso J; Duvillard P; Leboulleux S; Dromain C; Colao A; Schlumberger M; Baudin E
    Cancer; 2007 Jul; 110(2):265-74. PubMed ID: 17569104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of CD44 expression in gastrointestinal neuroendocrine tumors.
    Lai CH; Shan YS; Sy ED; Hsieh YH; Tsai HW; Lee JC; Lin PW
    Hepatogastroenterology; 2005; 52(64):1071-6. PubMed ID: 16001632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic aspects of gastric neuroendocrine tumors.
    Rindi G
    Am J Surg Pathol; 1995; 19 Suppl 1():S20-9. PubMed ID: 7762736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients.
    Tachezy M; Zander H; Marx AH; Gebauer F; Rawnaq T; Kaifi JT; Sauter G; Izbicki JR; Bockhorn M
    J Surg Res; 2011 Oct; 170(2):226-32. PubMed ID: 21816425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological characteristics and clinical specifications in gastroenteropancreatic neuroendocrine tumors: a study of 68 cases.
    Stoica-Mustafa E; Pechianu C; Iorgescu A; Hortopan M; Dima SO; Tomulescu V; Dumitraşcu T; Ungureanu C; Andronesi D; Popescu I; Herlea V
    Rom J Morphol Embryol; 2012; 53(2):351-5. PubMed ID: 22732805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine tumors of pancreas: how can we apply the 2006 TNM proposal?
    Mboti FB; Loi P; Nagy N; Myriam D; Gelin M; Closset J
    Hepatogastroenterology; 2010; 57(98):344-8. PubMed ID: 20583440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations between cyclooxygenase-2 expression and angiogenic factors in primary tumors and liver metastases in colorectal cancer.
    Nakamoto RH; Uetake H; Iida S; Kolev YV; Soumaoro LT; Takagi Y; Yasuno M; Sugihara K
    Jpn J Clin Oncol; 2007 Sep; 37(9):679-85. PubMed ID: 17846040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuroendocrine tumors of the gastroenteropancreatic system--reevaluation using the Capella classification].
    Brüwer M; Pahlov-Nejad T; Herbst H; Senninger N; Schürmann G
    Zentralbl Chir; 2003 Aug; 128(8):656-62. PubMed ID: 12931261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinicopathological and prognostic significance of MUC-1 expression in Japanese gastric carcinomas: an immunohistochemical study of tissue microarrays.
    Li XH; Zheng HC; Wang ZG; Takahashi H; Yang XH; Guan YF; Takano Y
    Anticancer Res; 2008; 28(2A):1061-7. PubMed ID: 18507055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.